JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1985) 104, 331-338       DOI: 10.1677/joe.0.1040331
© 1985 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckford, U.
Right arrow Articles by Hamer, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckford, U.
Right arrow Articles by Hamer, J. D.

Relationship between adrenocorticotrophin bioactivity in blood and cerebrospinal fluid of rhesus monkeys

U. Beckford, J. Herbert, M. T. Jones, N. D. Martensz, S. A. Nicholson, B. Gillham and J. D. Hamer

Adrenocorticotrophin levels, measured by a cytochemical bioassay, were determined in the plasma and cerebrospinal fluid (CSF) of adult female rhesus monkeys which were ovariectomized and receiving oestrogen replacement therapy. In control monkeys, ACTH bioactivity was found in both CSF (10·2±1·8 ng/l) and plasma (186 ± 51 ng/l) in samples taken at 14.00 h (lights on: 07.00–19.00 h). Dexamethasone treatment (0·2 mg/kg) twice daily for 4 days suppressed plasma ACTH levels (52·8 ± 25·2 ng/l) but had no effect on CSF levels (7·6± 2·7 ng/l). Raising plasma ACTH, either by daily injections of a long-acting preparation of ACTH(1–24) for 6 days or by bilateral adrenalectomy (and subsequently withdrawing cortisol replacement therapy) also resulted in no detectable changes in ACTH levels in the CSF. A regression analysis between ACTH in the plasma and CSF from samples taken throughout the experiments showed no correlation. In contrast, measurement of ACTH by radioimmunoassay, whilst satisfactory for determination of this peptide in plasma, could not identify authentic ACTH in the CSF. It is concluded that bioactive ACTH does not enter the CSF in detectable quantities from either the peripheral vascular compartment or from the animal's own pituitary gland, and that reducing ACTH secretion from the pituitary also has no effect on levels of ACTH in the CSF. This is in marked contrast to other pituitary peptide hormones, including prolactin, which is secreted together with ACTH during 'stress' but which, unlike ACTH, enters the CSF relatively easily.

J. Endocr. (1985) 104, 331–338




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
H. E. Gwirtsman, W. H. Kaye, D. T. George, D. C. Jimerson, M. H. Ebert, and P. W. Gold
Central and Peripheral ACTH and Cortisol Levels in Anorexia Nervosa and Bulimia
Arch Gen Psychiatry, January 1, 1989; 46(1): 61 - 69.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Society for Endocrinology.